0001143313-13-000009.txt : 20130212
0001143313-13-000009.hdr.sgml : 20130212
20130212172429
ACCESSION NUMBER: 0001143313-13-000009
CONFORMED SUBMISSION TYPE: 25-NSE/A
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20130212
DATE AS OF CHANGE: 20130212
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: YM BIOSCIENCES INC
CENTRAL INDEX KEY: 0001178347
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: 25-NSE/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32186
BUSINESS ADDRESS:
STREET 1: 5045 ORBITOR DRIVE
STREET 2: BUILDING 11 SUITE 400
CITY: MISSISSAUGA
STATE: A6
ZIP: 00000
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NYSE MKT LLC
CENTRAL INDEX KEY: 0001143313
IRS NUMBER: 522127241
FILING VALUES:
FORM TYPE: 25-NSE/A
BUSINESS ADDRESS:
STREET 1: 20 BROAD STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-5024
MAIL ADDRESS:
STREET 1: 20 BROAD STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Amex
DATE OF NAME CHANGE: 20090402
FORMER COMPANY:
FORMER CONFORMED NAME: NYSE Alternext US LLC
DATE OF NAME CHANGE: 20081009
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN STOCK EXCHANGE LLC
DATE OF NAME CHANGE: 20010620
25-NSE/A
1
primary_doc.xml
X0203
0001143313
NYSE MKT LLC
0001178347
YM BIOSCIENCES INC
001-32186
5045 ORBITOR DRIVE
BUILDING 11 SUITE 400
MISSISSAUGA
A6
ONTARIO, CANADA
LAW 4Y4
Common Stock
17 CFR 240.12d2-2(a)(3)
Paras Madho
Director
2013-02-12
EX-99.25
2
ymi.txt
NOTIFICATION OF THE REMOVAL FROM LISTING
AND REGISTRATION OF THE STATED SECURITIES
The null hereby notifies the SEC of its intention
to remove the entire class of the stated securities
from listing and registration on the Exchange at the
opening of business on February 25, 2013, pursuant
o the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on February 8, 2013
the instruments representing the securities comprising
the entire class of this security came to evidence, by
operation of law or otherwise, other securities in
substitution therefore and represent no other right
except, if such be the fact, the right to receive an
immediate cash payment.
The merger between YM BioSciences Inc.
and 3268218 Nova Scotia Limited, a wholly-owned
subsidiary of Gilead Sciences, Inc. became effective on
February 8, 2013. Each share of Common Stock of YM
BioSciences Inc. was converted into $2.95 in cash per share.
The Exchange also notifies the Securities and
Exchange Commission that as a result of the above
indicated conditions this security was suspended from
trading on February 11, 2013.